ReNeuron: Reneuron issues administration warning as biotech firm puts jobs at risk
Biotech business ReNeuron Group has warned it could enter administration and is preparing to make redundancies as its shares were suspended from trading.
Read full article »
ReNeuron is a Wales-based stem cell research company that develops engineered exosomes for the pharmaceutical sector.
Read more